<DOC>
	<DOCNO>NCT00909025</DOCNO>
	<brief_summary>Claudiximab monoclonal antibody specific gastric gastroesophageal adenocarcinoma . Preclinically , claudiximab show inhibit tumor growth kill cancer cell indirect ( complement-dependent cytoxicity , antibody-dependent cellular cytotoxicity ) direct mechanism ( antiproliferative proapoptotic effect ) . The aim phase I study establish safety , toxicity maximal tolerable dose single infusion claudiximab patient suffer relapsing , advance gastroesophageal gastric adenocarcinoma</brief_summary>
	<brief_title>Safety Tolerability Study Claudiximab Patients With Advanced Gastroesophageal Cancer</brief_title>
	<detailed_description />
	<criteria>Metastatic , refractory recurrent disease advance gastroesophageal cancer ( adenocarcinoma ) proven histology CLDN18.2 expression confirm immunohistochemistry Prior standard chemotherapy contain fluoropyrimidine , platinum compound and/or epirubicine , clinically appropriate docetaxel At least 1 measurable site disease accord RECIST criterion ( CTscans MRT old 6 week study entry ) Age ≥ 18 year ECOG performance status ( PS ) 01 Karnofsky Index 70100 % Life expectancy &gt; 3 month Platelet count ≥ 100,000/mm³ Hemoglobin ≥ 10 g/dl INR &lt; 1.5 Bilirubin normal AST ALT &lt; 2.5 time upper limit normal ( ULN ) ( 5 time ULN liver metastasis present ) Creatinine &lt; 1.5 x ULN Pregnancy breastfeed Prior allergic reaction intolerance monoclonal antibody Prior inclusion present study Less 3 week since prior antitumor radiation therapy Other investigational agent device concurrently within 4 week prior study Other concurrent anticancer therapy History positive test human immunodeficiency virus ( HIV ) antibody Known Hepatitis . Uncontrolled severe illness . Concurrent administration anticoagulation agent vitamin K antagonist Concurrent administration therapeutic dos heparin ( prophylactic dos acceptable )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>